Second-line chemotherapy with capecitabine (CAP) and oxaliplatin (OX) in patients with pancreatic or biliary tree adenocarcinoma (ADC).
Joan Manel Mane
Disclosure not yet available
Eluska Iruarrizaga
Disclosure not yet available
Itziar Rubio
Disclosure not yet available
Eva Fonseca
Disclosure not yet available
Estibaliz Iza
Disclosure not yet available
Raquel Casas
Disclosure not yet available
Ines Marrodan
Disclosure not yet available
Mireia Martinez
Disclosure not yet available
Ricardo Fernandez
Disclosure not yet available
Sergio Carrera
Disclosure not yet available